Satralizumab Single-Arm Pregnancy Safety Study: A Global, Observational, Single-Arm, 10-Year Study of Pregnancy and Infant Outcomes in Satralizumab-Exposed Women With Neuromyelitis Optica Spectrum Disorder First published 04/07/2022 Last updated 14/03/2024 EU PAS number:EUPAS47980 Study Ongoing